Rituximab-induced long-term remission in patients with refractory acquired hemophilia.
Abdallah
A
A
Coghlan
D W
DW
Duncan
E M
EM
Chunilal
S D
SD
Lloyd
J V
JV
D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006467:Hemophilia A / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008875:Middle Aged; D012074:Remission Induction; D000069283:Rituximab; D013997:Time Factors
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab